If the discovery of CCL14 as a predictor of persistent AKI is not the first one to suggest the role of monocytes/macrophages in the pathophysiology of AKI, especially in sepsis [133], it offers the opportunity to identify new approaches of AKI therapy. Here, CCL14 is linked to Sepsis.